Steen Hoffmann

Forskningsområder

Forskning om klamydia, syfilis, gonokokker, meningokokker og betahæmolytiske streptokokker, bl.a. med henblik på forekomst, antibiotikaresistens og typebestemmelse.

PubMed link

Steen Hoffmann

Priser

Hoechst Antibiotikapris, 1987

Thorvald Madsens legat, 1989

Ansvarsområder

Laboratoriebaseret overvågning af klamydia, syfilis, gonokokker, meningokokker og betahæmolytiske streptokokker, bl.a. med henblik på forekomst, antibiotikaresistens og typebestemmelse.

Publikationer

• Hovmand N, Lundbo LF, Kronborg G, Voss SS, Sandholdt H, Hoffmann S, Valentiner-Branth P, Benfield T. Recent increased incidence of invasive serogroup W meningococcal disease: A retrospective observational study. Int J Infect Dis. 2021 Jul;108:582-587. doi: 10.1016/j.ijid.2021.05.086. Epub 2021 Jun 5.
  
  
• Brueggemann AB, ….., Hoffmann S, …... et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021 Jun;3(6):e360-e370. doi: 10.1016/S2589-7500(21)00077-7.
  
  
• Slotved HC, Fuursted K, Kavalari ID, Hoffmann S. Molecular Identification of Invasive Non-typeable Group B Streptococcus Isolates From Denmark (2015 to 2017). Front Cell Infect Microbiol. 2021 Mar 29;11:571901. doi: 10.3389/fcimb.2021.571901. eCollection 2021.
  
  
• Jacobsson S, Cole MJ, Spiteri G, Day M, Unemo M; Euro-GASP Network.Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016. BMC Infect Dis. 2021 Mar 18;21(1):273. doi: 10.1186/s12879-021-05931-0.
  
  
• Unemo M, Ahlstrand J, Sánchez-Busó L, Day M, Aanensen D, Golparian D, Jacobsson S, Cole MJ; European Collaborative Group. High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. J Antimicrob Chemother. 2021 Apr 13;76(5):1221-1228. doi: 10.1093/jac/dkab024.